Eli Lilly (LLY) announces that from January 1st 2027, Zepbound, Mounjaro and Orforglipron will be available through Medicare Part D participating plans
Importance
Level 1
- On cmmi balance model for GLP-1s, patient's cost-sharing will be limited to USD 245/month plus dispensing fee before patients reach their deductible
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ELI LILLY & CO#LLY.US#FOREX#EQUITIES#METALS#EU SESSION#US SESSION#PHARMACEUTICALS#METALS & MINING#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#DXY#US EQUITIES